Identification and Evaluation of Benzimidazole- Agonists of Innate Immune Receptor NOD2
ACS Infectious Diseases · 13.02.2026 · 12 (2) · 600-610
DOI: 10.1021/acsinfecdis.5c00737 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 13.01.2026. Verfasst von Liora Wittle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States. Hauptthemen laut MEDLINE: Nod2 Signaling Adaptor Protein, Benzimidazoles. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
- Department of Pathology, University of Virginia, Charlottesville, Virginia 22908, United States.
ORCID-Profile: Karl L Ocius, Marcos M Pires
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
Zitieren
APA
Wittle, L., Ocius, K. L., Chordia, M. D., van Wagoner, C., Bullock, T. N. J., & Pires, M. M. (2026). Identification and Evaluation of Benzimidazole- Agonists of Innate Immune Receptor NOD2. ACS Infectious Diseases, 12(2), 600-610. https://doi.org/10.1021/acsinfecdis.5c00737
Vancouver
Wittle L, Ocius KL, Chordia MD, van Wagoner C, Bullock TNJ, Pires MM. Identification and Evaluation of Benzimidazole- Agonists of Innate Immune Receptor NOD2. ACS Infectious Diseases. 2026;12(2):600-610. doi:10.1021/acsinfecdis.5c00737
BibTeX
@article{Wittle2026,
author = {Wittle, Liora and Ocius, Karl L and Chordia, Mahendra D and van Wagoner, Carly and Bullock, Timothy N J and Pires, Marcos M},
title = {Identification and Evaluation of Benzimidazole- Agonists of Innate Immune Receptor NOD2},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {2},
pages = {600--610},
doi = {10.1021/acsinfecdis.5c00737}
}
EUVIMED